Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis at ARVO 2015 Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Clinically Relevant, Statistically Significant Improvements of Symptoms in the Late Phase of Allergic Conjunctivitis with EBI-005 Supports Advancing to a Phase 3 Natural Environment Study
